T BX20 encodes a key transcription factor that is expressed in the heart, eyes, ventral neural tube, and limbs during embryonic development. 1 It belongs to the phylogenetically conserved family of Tbox genes that share a common T-box DNA-binding domain. In zebrafish, tbx20 is expressed in the developing heart and dorsal aorta 2, 3 and regulates cardiac development. 4 Tbx20 knockout (KO) in mice causes a variety of cardiac defects and results in embryonic lethality around embryonic day 10.5. [5] [6] [7] In humans, mutations in TBX20 are associated with a complex spectrum of developmental abnormalities, including defects in septation, chamber growth, valvulogenesis, and cardiomyopathy. 8 TBX20 regulates endocardial cushion cell proliferation, extracellular matrix gene expression, and septation, 9, 10 in part via modulation of Lef1 and the Wnt/β-catenin pathway. 11 In addition, TBX20 promotes heart chamber formation in part through repression of TBX2. [5] [6] [7] Whereas a partial deficiency of TBX20 may cause congenital heart defects, a greater deficiency of TBX20 hinders motoneuron development.
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Tbx20 is also expressed in the adult heart, where overexpression of Tbx20 in adult cardiomyocytes promotes proliferation 13, 14 and improves myocardial infarction outcomes in a mouse model. 13, 15 In endothelial cells (ECs), TBX20 upregulates peroxisome proliferatoractivated receptor-γ and suppresses the generation of reactive oxygen species and the expression of adhesion molecules generated in response to oxidized lowdensity lipoproteins. 16 However, it is unknown whether TBX20 is involved in blood vessel formation and controls angiogenic processes.
The chimeric heterokaryon model was first used to identify novel genes in nuclear reprogramming to pluripotency. 17 We have adopted the model to identify novel genes in endothelial development. 18 In this model, murine embryonic stem cells (ESCs) are fused with adult human ECs, and RNA sequencing is performed at intervals to assess changes in global gene expression of the resulting hybrid cells. We found that factors maintaining endothelial phenotype act on the ESCs to induce the expression of genes associated with endothelial lineage. 18 Using this model, we discovered novel genes implicated in endothelial development. TBX20 was upregulated early after cell fusion in this chimeric heterokaryon model, which prompted us to explore the role of TBX20 in endothelial development. Our subsequent work illuminates a new TBX20-choreographed molecular pathway for developmental and pathological angiogenesis.
METHODS
The data, analytical methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure on request.
Animal Husbandry
All animals were maintained in a specific pathogen-free facility at Houston Methodist Research Institute in Houston, TX. Animal use and care were approved by the Houston Methodist Animal Care Committee in accordance with institutional animal care and use guidelines. Nonobese diabetic/ severe combined immunodeficiency mice were generated in our laboratory. Zebrafish AB wild-type (WT), mutant, and Tg(fli1: EGFP) y1 fish lines were maintained and bred as described previously. 19, 20 
Matrigel Plug Assay
To assess the role of TBX20 in angiogenesis in vivo, Matrigel was mixed with 50 ng/mL vascular endothelial growth factor (VEGF), 30 U/mL heparin to stabilize VEGF, 21 and 2 μmol/L scramble siRNA or siRNA targeting Tbx20 in a final volume of 400 μL and injected subcutaneously into the lower abdominal region of severe combined immunodeficiency mice. After 5 days, the Matrigel plugs were removed for
Clinical Perspective
What Is New?
• We report a novel TBX20-choreographed signaling pathway that functions as a proangiogenic capacitor to regulate developmental and pathological angiogenesis.
• In this signaling pathway, with vascular endothelial growth factor stimulation, the transcription factor TBX20 upregulates PROK2 (prokineticin 2), which is secreted from endothelial cells, engages its receptor PROKR1 (prokineticin receptor 1), and thereby promotes angiogenesis in an autocrine manner.
• This signaling pathway (TBX20-PROK2-PROKR1) is highly conserved in that it functions in zebrafish vascular development and the angiogenic response to ischemia in a mouse model of peripheral artery disease.
• Our study indicates the selective role of TBX20 in endothelial migration but not proliferation.
What Are the Clinical Implications?
• 
Murine Hind-Limb Ischemia
Hind-limb ischemia was induced in 9-month-old male WT mice as previously reported with slight modification. [21] [22] [23] Briefly, unilateral hind-limb ischemia was induced by ligating the femoral artery and its major branches. Afterward, the mice were housed individually, and blood flow in the affected and control limbs was imaged up to 21 days. In some experiments, recombinant PROK2 (prokineticin 2) proteins (0.1 μg/g body weight) or PBS was injected intramuscularly immediately and 7 days after surgery. Blood perfusion was monitored before and immediately after surgery and 4, 7, 11, and 14 days postoperatively. The clinical ischemia score index was used to assess tissue loss, as modified from the previously reported method. 24 The criteria used were as follows: 0=no changes; 1=discoloration/necrosis of the nails; 2=dis-coloration/necrosis of the toes; 3=foot necrosis; 4=leg necrosis (up to the gastrocnemius muscle); and 5=autoamputation (loss of limb). There were 2 independent observers who were blinded to the group assignment. At day 14 in the postoperative period, the hind-limb muscles from the operated and contralateral limbs were collected for histology. Eight male mice were used for each experimental group. Total capillary density of the ischemic hind-limb cross sections was determined by staining the slides with rabbit anti-mouse CD31 (BD Biosciences), followed by horseradish peroxidase-conjugated secondary antibody.
Laser Doppler-Based Tissue Perfusion Measurement
Blood flow to the ischemic or nonoperated (nonischemic) hind limb was assessed with a PeriScan PIM3 laser Doppler system (Perimed AB, Sweden) as described previously. 22, 23 Animals were prewarmed to a core temperature of 37.5°C, and heart rate was constantly monitored for signs of stress from overheating. Hind-limb blood flow was measured preoperatively and postoperatively on selected days (days 0, 4, 7, 11, and 14). Blood perfusion rate was measured via laser Doppler scans. The level of perfusion in the ischemic and unoperated hind limbs was quantified with the mean pixel value within the region of interest, and the relative changes in hind-limb blood flow were expressed as the ratio of the left (ischemic) over right (unoperated) laser Doppler-detected blood perfusion.
Generation of Zebrafish Mutants Using CRISPR/Cas9
The CRISPR/Cas9-mediated gene KO technology in WT AB line zebrafish was as previously described. 25 In brief, the target sequences for tbx20, prok2, and prokr1a were 5′-TGTGCTAATGGACATAGTTC-3′, 5′-GGATGCACA TTCGGAGACTG-3′, and 5′-GGCAATATCAGACTTTCTGG-3′, respectively. Complementary target oligonucleotides were annealed and inserted into pT7-guide RNA vector. Guide RNA was synthesized with the HiScribe T7 Quick High Yield RNA Synthesis kit. The pCS2-nCas9n was linearized with NotI, and capped Cas9 mRNA was synthesized with mMESSAGE mMACHINE SP6 kit. The guide RNA (50-100 ng/μL) and Cas9 mRNA (150-200 ng/μL) were mixed and injected into 1-cellstage WT AB embryos.
For detecting the zebrafish mutants, genomic DNA was extracted from individual zebrafish larva, and a short genomic region (300-500 bp) flanking the target site was polymerase chain reaction (PCR) amplified. Purified PCR products (200 ng) were denatured, reannealed, and then digested with T7 Endonuclease I (NEB). PCR products of positive mutants were subcloned into pMD20-TA vector (Clontech). After transformation into competent cells and overnight culture at 37°C, a single colony was selected for sequencing.
RNA Extraction and Quantitative Real-Time PCR
Quantitative real-time PCR (qRT-PCR) in zebrafish and mice was performed as previously described. 19, [26] [27] [28] Primers used in zebrafish study are list in Table I in the online-only Data Supplement. Please see the online-only Data Supplement for details.
Whole-Mount Alkaline Phosphatase Staining
Zebrafish embryos were fixed in 4% paraformaldehyde at 3 days postfertilization (dpf) and stained for endogenous alkaline phosphatase activity similar to the previously described method. 29, 30 Briefly, the embryos were fixed in 4% paraformaldehyde overnight at room temperature and were serially dehydrated and permeabilized in 25%, 50%, and 75% methanol in phosphate-buffered saline with 0.1% Tween-20 (PBST), pH 5.5 (vol/vol), and 100% methanol, followed by rehydration in 75%, 50%, and 25% methanol and finally in PBST. After equilibration with alkaline phosphatase buffer, the embryos were stained with the nitro-blue tetrazolium chloride; 9-bromo-4-chloro-3-indolylphosphate toluidine solution at room temperature for 20 minutes. The reaction was stopped with stop buffer (PBST with 0.25 mmol/L EDTA, pH 2.2). Embryos were mounted in glycerol for image capture.
Confocal Imaging and Data Analysis
Anesthetized embryos at the indicated stage were mounted in 1.0% low-melt agarose (Sigma Aldrich) for imaging. 19 Images were acquired with the use of an Olympus FluoView FV1000 laser scanning confocal microscope. Z stacks were acquired with a 3-μm z step, and images were 3-dimensional rendered. Neurolucida software (MBF Bioscience) was used to analyze the length of intersegmental vessels (ISVs) and subintestinal vessels (SIVs).
Data Analysis
Results are expressed as mean±SEM, and statistical analysis was performed with the Student t test or 1-way or 2-way ANOVA followed by the Sidak multiple-comparisons test with Prism software. *P<0.05 was considered statistically significant. **P≤0.01, ***P≤0.001, and ****P≤0.0001.
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RESULTS
Tbx20 Is Robustly Upregulated in a Heterokaryon Model
To examine the Tbx20 gene expression in endothelial differentiation, 2 model systems were used: one is the mouse ESC differentiation to ECs and the other one is heterokaryon-induced differentiation of pluripotent stem cells into endothelial lineage. During the mouse ESC differentiation into endothelial lineage, 18 Tbx20 gene expression was upregulated by 16-fold at day 8 of differentiation compared with mouse ESCs ( Figure Ia in the online-only Data Supplement). In a heterokaryon model, 18 fusing mouse ESCs with human umbilical vein ECs (HUVECs) induced differentiation of pluripotent stem cells toward endothelial lineage. We found that Tbx20 gene expression was upregulated and peaked at 4-fold at 6 hours after heterokaryon formation compared with coculture control (CT; Figure Ib in the onlineonly Data Supplement).
Tbx20 Is Essential for Developmental Angiogenesis in Zebrafish
On the basis of our findings from the heterokaryon model, we hypothesized that TBX20 transcriptionally regulates vascular development. Accordingly, we first knocked down tbx20 in zebrafish embryos by injecting tbx20 morpholino antisense oligos (MO) at the 1-cell-stage embryo of Tg(fli1:EGFP) y1 zebrafish. These animals express enhanced green fluorescent protein in the endothelium, 31 permitting visualization of vascular development in both the trunk and yolk sac regions. At 30 hours postfertilization (hpf), the tbx20 knockdown (KD) embryos, compared with controls, showed no apparent change in vasculogenesis as evidenced by normal dorsal aorta and cardinal vein formation (Figure 1A) . At this time point, ISVs, which sprout from dorsal aorta via angiogenesis, including endothelial proliferation and migration, 32 reached the dorsal roof of the neural tube in control embryos ( Figure 1A and 1C and Figure Ic in the online-only Data Supplement). In contrast, ISVs sprouted only halfway through their dorsal trajectory and stalled at the boundary between the notochord and neural tube in tbx20 morphants ( Figure 1A and 1C and Figure Ic in the online-only Data Supplement). In addition, tbx20 deficiency suppressed the development of SIVs, which form bilaterally over the dorsal-lateral aspect of the zebrafish yolk at 3 dpf, in the shape of a basket that extends from the ventral edge of the somite 33 ( Figure 1B and 1C and Figure Id in the online-only Data Supplement). Coinjection of the zebrafish tbx20 mRNA, which lacked the MO targeting site, significantly rescued the ISV and SIV defects in tbx20 morphants ( Figure 1A through 1C and Figure   Ic and Id in the online-only Data Supplement). All the above data suggest that tbx20 is required for developmental angiogenesis.
Because MO-mediated transient gene KD could have off-target effects, 34 we also generated tbx20 KO mutants to further validate the MO-induced vascular defects. We generated the tbx20 KO zebrafish mutants using CRISPR/Cas9 to target the third exon of tbx20 ( Figure 1D ). Zebrafish full-length tbx20 encodes a protein of 446 amino acids. The tbx20 mutants had a 4-bp deletion starting at the 453 nucleic acid position (Figure 1E ), resulting in frameshift and a premature stop codon encoding a truncated protein of only 193 amino acids ( Figure 1F ). This mutation disrupted the original Tbox domain (98-290 amino acids) and the DNA binding domain, 35 designed to abolish its transcriptional activity. Blood vessels in tbx20 mutants showed incomplete vessel length, attenuated sprouting of SIVs, and reduced vascular area compared with controls ( Figure 1G and 1H) as examined with whole-mount staining for endogenous alkaline phosphatase activity. 30 These phenotypes are congruent with tbx20 morphants, suggesting that the angiogenic phenotype of tbx20 morphant was not the result of MO off-target effect and that tbx20 regulates in vivo vascular development in zebrafish. Previous studies found that constitutive KO mutations, but not transient KD, may activate compensatory mechanisms 36 and thus cause discrepancies in the observed phenotype between KD and KO animals. However, we observed impaired developmental angiogenesis in both tbx20 KD and KO, suggesting that tbx20 plays a critical role in developmental angiogenesis, uncompensated by other mechanisms.
ISV angiogenic sprouts originate at ≈20 hpf from the dorsal aorta, which condenses as a distinct cord of ECs at the trunk midline starting at the 15 somite stage (16.5 hpf). 32 Because tbx20 is reported to regulate heart development, we next examined whether the impaired angiogenesis is secondary to a defect of heart development and associated hemodynamic perturbations. We used the pan-cardiac marker cardiacmyosin light chain-2 (cmlc2) to examine the formation of arterial precursors as reported. 37 At 24 hpf, cmlc2 expression in tbx20 morphants was comparable to that in control animals, suggesting that the specification of arterial precursors proceeds normally in tbx20-MO-injected animals. At 30 hpf, we did not observed abnormal heart development in low-dose tbx20-MO-injected animals (Figure II and Table II in the online-only Data Supplement), which agreed with a previous report that tbx20 is not essential for the early (up to 24 hpf) differentiation or morphogenesis of the heart. 4 Together, these data indicate that the impaired angiogenesis in Tbx20-deficient animals is not an indirect effect of disturbed hemodynamics caused by dysregulated heart development.
Tbx20 Is Required for Pathological Angiogenesis in Mice
To determine whether Tbx20 has a role in pathological angiogenesis in adult animals, we prepared Matrigel that was mixed with Tbx20 siRNA or scrambled control siRNA and injected the Matrigel subcutaneously into nonobese diabetic/severe combined immunodeficiency mice. The Matrigel is in a liquid form at 4°C and condenses into a solid plug when injected into mice. This model is widely used to assess angiogenesis. Our data demonstrated that Matrigel plugs containing the scrambled siRNA showed robust angiogenic response and were imbued with vessels containing red blood cells as evidenced by bright-field imaging and by hematoxylin and eosin staining (Figure 2A and 2B ). In contrast, intraplug vessels and blood content were markedly reduced in those plugs containing Tbx20 siRNA (Figure 2A and 2B) . Fluorescence-activated cell sorter analysis of the cell content in Matrigel plugs revealed a decrease in CD144 + ECs ( Figure 2C and 2D) from Tbx20 siRNA-containing Matrigel plugs (0.41% versus 4.96% in CT). We verified successful KD of Tbx20 gene expression in the Matrigel plug using qRT-PCR ( Figure 2E) .
To explore the role of TBX20 in angiogenesis in vitro, we knocked down TBX20 in HUVECs and examined the effect on tube formation, migration, and proliferation. We generated a stable TBX20 KD line and CT HUVECs using lentiviral vector-mediated delivery of shRNA against Figure 2H ) and suppressed cell migration in a scratch assay ( Figure 2I and 2J) Together, these data suggest that TBX20 regulates angiogenesis mainly through EC migration.
PROK2 Mediates the Effect of TBX20
To identify downstream molecules of TBX20 in angiogenesis, we examined the gene expression of 84 angiogenesis-related genes using a Qiagen Angiogenesis RT Profiler PCR Array. Sixteen genes were downregulated >2-fold in the TBX20 KD HUVECs compared with CT ( Figure 3A ). Among them, PROK2 was downregulated >12-fold, one of the most pronouncedly responsive genes in TBX20 KD cells. PROK2 is a secreted protein and is known to have diverse functions in angiogenesis, 38, 39 behavioral circadian rhythm, 40 olfactory bulb morphogenesis, 41 and reproductive function. 42 In adult zebrafish, prok2 is involved in both constitutive and injury-induced neurogenesis. 43 To examine whether PROK2 mediated the impaired angiogenic processes in TBX20 KD cells, we determined the rescue effect of PROK2 on the defective network formation in TBX20-deficient HUVECs. As expected, supplementation with exogenous PROK2 restored normal tube formation in TBX20 KD HUVECs ( Figure 3B ).
In addition, we generated TBX20 overexpression HUVECs and examined the PROK2 gene expression. Both qRT-PCR ( Figure 3C ) and Western blot analysis (Figure 3D ) validated the stable overexpression of TBX20. As expected, TBX20 overexpression further promoted EC migration ( Figure 3E ) and strongly upregulated PROK2 gene expression ( Figure 3F ). Similarly, Prok2 gene expression was downregulated from Matrigel plugs containing Tbx20 siRNA compared with those with CT siRNA ( Figure 3G ). Furthermore, KD of tbx20 also diminished prok2 expression in zebrafish embryo ( Figure 3H ). Because VEGF activates the major proangiogenic pathway for angiogenesis, we assessed hierarchical relations of VEGF, TBX20, and PROK2 in HUVECs. VEGFA165 stimulation upregulated TBX20 and PROK2 gene expression ( Figure 3I and 3J) , an effect that was abolished by TBX20 KD (Figure 3K and 3L) , suggesting that TBX20 augments VEGF-induced PROK2 gene expression. Although TBX20 KD also robustly downregulated fibroblast growth factor 1 (FGF1) and FGF receptor 3 (FGFR3) expression ( Figure 3A ), Fgf1 and Fgfr3 overexpression failed to rescue the angiogenic defects in Tbx20-deficient animals ( Figure IVa and IVb in the online-only Data Supplement). Collectively, these results suggest that PROK2 functions downstream of TBX20 in regulating angiogenesis.
Prok2 Regulates Developmental Angiogenesis
We postulate that loss of prok2 would phenocopy the angiogenesis defects in tbx20 morphants because Prok2 acts downstream of Tbx20. Indeed, prok2 KD abolished ISV formation at 30 hpf ( Figure 4A and 4C) and SIV development at 3 dpf ( Figure 4B and 4C) , similar to that in tbx20 morphants. The ISV and SIV defects caused by prok2 KD were largely reversed by the administration of zebrafish prok2 mRNA that did not include the MO targeting site ( Figure 4A through 4C and Figure Va and Vb in the online-only Data Supplement).
We then generated prok2 KO zebrafish mutants ( Figure 4D through 4F) , which showed abnormal SIV formation with reduced vessel area, decreased SIV length, and attenuated sprouting ( Figure 4G and 4H) . Altogether, the prok2 deficiency phenocopied the tbx20 deficiency. These findings suggest that Prok2 functions as a key downstream component of Tbx20 in regulating developmental angiogenesis.
PROK2 Exerts Its Angiogenic Effects Largely Through Prokineticin Receptor 1
PROK2 signals through 2 G-protein-coupled receptors (GPCRs), PROKR 1 44 and 2. 45 PROKR1 is reported to mediate the proangiogenic effect of PROK2 in the cardiovascular system. 46 In addition, PROKR1 overexpression promotes neovascularization, 47 whereas PROKR2 overexpression induces an inflammatory response. 48 However, the in vivo genetic evidence for PROKR1 in angiogenesis remains unknown.
There is only a prokr1 gene but not a prokr2 gene in zebrafish. Zebrafish have 2 different prokr1 genes, prokr1a and prokr1b, which are located on chromosomes 1 and 13, respectively. Zebrafish prokr1a shares the highest homolog with that of mouse and human PROKR1. We thus hypothesized that prokr1a encodes the major receptor for Prok2 in zebrafish and further hypothesized that loss of function of prokr1a would limit angiogenesis, similar to that in prok2-or tbx20-deficient animals. Indeed, similar to tbx20 and prok2 KD morphants, loss of prokr1a resulted in a substantial impairment of ISV formation at 30 hpf and SIV formation at 3 dpf ( Figure 5A ). The ISV and SIV defects caused by prokr1a-MO were alleviated by the administration of exogenous prokr1a mRNA, which did not contain the MO binding site ( Figure 5A through 5C and Figure VIa and VIb in the online-only Data Supplement). We next generated the prokr1a KO zebrafish mutant ( Figure 5D through 5F). It is notable that the prokr1a mutants manifested less SIV sprouting than control animals at 3 dpf ( Figure 5G and 5H) . These results suggest that the Prokr1a, a receptor for Prok2, orchestrates angiogenesis in zebrafish.
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In HUVECs, both putative PROK2 receptors PROKR1 and PROKR2 can be detected on the cell surface ( Figure 6A ). Both PROKR1 and PROKR2 KD by siR-NA reduced their relative mRNA expression >70% ( Figure 6B ). Only PROKR1 KD significantly impaired PROK2-mediated angiogenesis ( Figure 6C ) and cell migration ( Figure 6D ), suggesting that PROK2 controls angiogenesis and EC migration through PROKR1. In addition, PROKR1 KD abolished the PROK2-engaged activation and phosphorylation of the ERK (extracellular signal-regulated kinase) 1/2 and Akt pathway in HUVECs ( Figure 6E through 6G) . All data indicate that PROKR1 mediates the effect of PROK2 on angiogenesis and endothelial migration. Circulation. Previous studies demonstrate that PROKR1 signaling induces neovascularization, 47 whereas PROKR2 signaling governs inflammatory response and impairs endothelial integrity. 48 To further verify that Prokr1 is the major GPCR for Prok2 in angiogenesis, we overexpressed prokr1a mRNA in prok2 morphants and found that forced Prokr1a expression corrected impaired angiogenesis ( Figure 7A and 7B) .
Loss of prok2, similar to tbx20 deficiency, downregulated prokr1a but not prokr1b gene expression (Figure 7C through 7E) , suggesting that Prok2 positively regulates Prokr1a expression during development. We further tested whether prok2-prokr1a signaling mediated the effect of Tbx20 on angiogenesis. As expected, injection of prok2 or prokr1a mRNA reversed to a large extent restricted angiogenesis caused by Tbx20 or Prok2 deficiency ( Figure 7A and 7B) . Collectively, these results suggest that Prok2-activated Prokr1a signaling controls angiogenesis downstream of Vegf-induced Tbx20 upregulation.
PROK2 Enhances Functional Recovery From Hind-Limb Ischemia
To examine whether the Tbx20-Prok2 pathway is involved in angiogenesis during hind-limb ischemia, we examined the gene expression of Tbx20, Prok2, and Prokr1 during the recovery after hind-limb ischemia. Both Tbx20 gene expression and Prok2 gene expression were increased ( Figure 8A and 8B ), but Prokr1 gene expression remained stable ( Figure 8C ). It is notable that Tbx20 gene expression was upregulated as early as 4 days after ischemia.
Because Prok2 gene expression was elevated at later time points, we hypothesize that early application of PROK2 will promote angiogenesis and functional recov- 
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ery from hind-limb ischemia. We injected intramuscular recombinant PROK2 protein or vehicle. Notably, we observed increased blood perfusion recovery in the ischemic limb with PROK2 treatment (Figure 8D and 8F ). In addition, the PROK2-treated mice were improved clinically, as documented by an observer blinded to treatment group using an established clinical scoring system ( Figure 8E ). PROK2 administration also increased gastrocnemius capillary density, as shown by greater CD31 staining ( Figure 8G ). The results suggest that PROK2 treatment enhances functional blood vessel formation after hind-limb ischemia injury.
DISCUSSION
Previous studies showed that the transcriptional factor TBX20 regulates a variety of developmental processes, in particular heart development. [4] [5] [6] [7] [8] Here, we demonstrate for the first time that TBX20 mediates angiogenic processes in vitro, orchestrates vascular development in zebrafish, and modulates the angiogenic response to ischemia in mice. We identified PROK2 as a downstream target for TBX20 and further validated that the PROK2-PROKR1 signaling axis mediated the effect of TBX20 on angiogenesis. Thus, our study defined a novel TBX20-regulated signaling pathway for angiogenesis ( Figure VII in the online-only Data Supplement).
Identification of TBX20 as a Novel Transcription Factor for Angiogenesis: Selective Role in Cell Migration
We identified TBX20 as a candidate for endothelial lineage using a heterokaryon model to screen for genes regulating EC development. In this model, an array of The intensity of pERK1/2, total ERK1/2, pAkt, and total Akt immunoblotting signals was measured and normalized with baseline level at 0 minutes. Scale bar: 100 μm. All data are presented as mean±SEM; n=3. *P≤0.05. **P≤0.01.
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3-kinase]-Akt, 49 PLC-r-ERK1/2 [phospholipase C-γ-extracellular signal-regulated kinase 1/2], 50 sarcoma virus oncogene-small GTPase, 51 and p38 52 ) that are involved in EC migration or proliferation. 53 We will investigate the particular effector(s) of VEGF receptor 2 signaling pathway 53 responsible for TBX20-regulated angiogenesis in future studies. In our preliminary studies, we found that in the in vitro scratch assay, which initiates cell migration, TBX20 expression was increased (data not shown). It will be interesting to determine whether TBX20 expression is enriched in tip cells, the cell type that spearheads cell migration during angiogenesis.
TBX20-PROK2-PROKR1 Signaling in the Relay of VEGF Activity: A Proangiogenic Capacitor
Our initial studies suggest that TBX20 regulates angiogenesis. Taking advantage of TBX20 as a transcription factor, we performed unbiased qRT-PCR array for angiogenic genes to identify the TBX20 downstream target(s). We found that Prok2 was dramatically downregulated in response to TBX20 KD. Our subsequent study in animals and in vitro validated that TBX20 loss and gain of function decreased and increased PROK2 expression, respectively. FGF1 and FGFR3 are markedly reduced in TBX20-deficient ECs, but forced expression of these genes could not correct disrupted angiogenesis in Tbx20 KD zebrafish. Thus, our data suggest that Prok2 is a direct downstream target of TBX20 and that its activity is not dependent on FGF. Administration of PROK2 enhanced angiogenesis and functional recovery from hind-limb ischemia, suggesting that PROK2 can be a potential therapeutic target. PROK2 signaling controls endothelial migration and angiogenesis preferentially through PROKR1, but not PROKR2. PROKR1 KD impairs proper activation and phosphorylation of ERK1/2 and Akt. However, a survey of available TBX20 Ten-month-old mice were subjected to hind-limb ischemia, and recombinant PROK2 (0.1 μg/g body weight) or PBS was injected intramuscularly right after the surgery and at day 7 after surgery. Blood perfusion was monitored before, immediately after, and at 4, 7, 11, and 14 days after the surgery. Limb muscles were dissected at day 14 for histological analysis. A through C, Gene expression of T-box 20 (Tbx20; A), Prok2 (B), and prokineticin receptor 1 (Prokr1; C) of limb muscles dissected at 0, 4, 14, and 21 days after surgery in the coculture control (CT) group. D, Mean perfusion ratio of ischemic to unoperated limb at different time points after injury. E, Hind-limb ischemia score at day 14. F, Ultrasound imaging of blood perfusion in CT or PROK2-treated mice 14 days after ischemia. G, CD31 immunohistochemistry analysis of microvessels in the hind-limb muscle of CT or PROK2-treated animals. All data are presented as mean±SEM; n=8 per group. *P≤0.05 vs CT group.
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chromatin immunoprecipitation data failed to reveal TBX20 binding on PROK2 proximal promoter. Several reasons may account for this. First, the quality of the chromatin immunoprecipitation data may not be optimal enough to allow a high-resolution analysis of TBX20 binding to the PROK2 promoter region. Second, there may be some enhancer region that is far away from the actual gene body regulating its expression. Third, TBX20 may regulate PROK2 expression epigenetically or through a noncoding RNA. The detailed mechanism of action by which TBX20 regulates PROK2-PROKR1 signaling in angiogenesis warrants further investigation. PROK2, known as a member of endocrine glandderived VEGF family, is expressed in the endocrine tissues. In the testis where the turnover of ECs is high, PROK2 and its receptor PROKR1 are highly expressed, which may help maintain vascular integrity and density in the adult. 54 During early pregnancy, PROKR1 is expressed in the fetal ECs to support gestation. Our study identified the role of this pathway in developmental and pathological angiogenesis. Although several GPCR ligands such as S1P or Apelin regulate angiogenesis, [55] [56] [57] they usually use a paracrine mechanism, that is, other cells that secrete the ligands acting on ECs. We elucidated a novel autocrine GPCR signaling cascade in which EC-derived GPCR ligand PROK2 controls endothelial migration and angiogenesis. Angiogenesis is required for embryogenesis and tissue remodeling/repair after ischemia. Because partial VEGF loss or gain of function causes embryonic lethality, [58] [59] [60] it is essential to evolve multiple layers of control mechanisms to ensure proper VEGF signaling, for example, an alternative pathway to sustain the proangiogenic effect. We speculate that this TBX20-PROK2-PROKR1 pathway may thereby function as a "biological capacitor" to relay and prolong the angiogenesis-promoting effect of VEGF.
Conclusions
Our studies highlight a previously unappreciated mechanism for angiogenesis in which VEGF-stimulated TBX20 activates PROK2-PROKR1 signaling. This pathway might be therapeutically targeted to treat diseases associated with dysregulated angiogenesis.
